Further, with Bridge scheduled to expire at the end of 2027, a question looms regarding what will happen when the program expires
"Psoriasis management has traditionally focused on controlling skin symptoms, but these findings emphasize the need to consider the wider health risks faced by patients," lead author Ralf Ludwig, M.D., Ph.D., also from University of Lbeck, said in a statement
Das P, Tanious M, Fritz K, Dodd S, Dean OM, Berk M, et al
Understanding why you might not be losing weight on semaglutide or exploring why tirzepatide stopped working is more productive than adding unproven supplements to your protocol
Contraindications include active malignancy, uncontrolled diabetes, pregnancy, or history of certain cancers
Common injection site problems that sabotage weight loss Even with proper rotation, injection site issues can arise